Article Information
History
- December 13, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- R. Bihariesingh-Sanchita,b,*,
- R. Bansiec,
- N. Ramdhania,
- R. Mangrooc,
- D. Bustamentea,
- E. Diazb,
- C. Fung A Foeka,
- I. Thakoerd,
- S. Vredenc,
- Z. Choudhrye,
- A.B. van ‘t Woutf,g,
- D.A. Diavatopoulosh,i and
- A.P. Nierichj
- aDepartment of Anesthesiology, Academic Hospital Paramaribo, Paramaribo, Suriname
- bDepartment of Intensive Care, Academic Hospital Paramaribo, Paramaribo, Suriname
- cDepartment of Internal Medicine, Academic Hospital Paramaribo, Paramaribo, Suriname
- dDepartment of Radiology, Academic Hospital Paramaribo, Paramaribo, Suriname
- eDepartment of Nephrology and Therapeutic Apheresis, Horacio Oduber Hospital, Aruba
- fAlphaBiomics Limited, London, United Kingdom
- gvan ‘t Wout Pharma Consulting, Amsterdam, The Netherlands
- hSection Paediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands
- iRadboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands
- jHemoClear BV, Zwolle, The Netherlands
- ↵*Corresponding author
R. Bihariesingh-Sanchit, Department of Anesthesiology, 1-3 Flustraat, Paramaribo, Suriname Tel.: +597442222 (ext. 601). E-mail: r-bihariesingh{at}hotmail.com
Posted December 13, 2022.
Reduced mortality among COVID-19 ICU patients after treatment with HemoClear convalescent plasma in Suriname
